4//SEC Filing
Haines Timothy 4
Accession 0001171843-18-004581
CIK 0001359931other
Filed
Jun 10, 8:00 PM ET
Accepted
Jun 11, 4:33 PM ET
Size
6.7 KB
Accession
0001171843-18-004581
Insider Transaction Report
Form 4
Haines Timothy
Director10% Owner
Transactions
- Award
Stock Option (Right to Buy)
2018-06-08+12,700→ 12,700 totalExercise: $2.50Exp: 2028-06-07→ Common Stock (12,700 underlying)
Footnotes (3)
- [F1]Tim Haines (the "Reporting Person") was granted options to purchase shares of common stock in consideration of his services as a director of the Issuer (the "Options"). The Options were granted on June 8, 2018 and the shares underlying the Options will vest 100% at the earlier of (i) June 8, 2019 and (ii) the Issuer's next annual meeting of stockholders.
- [F2]The Reporting Person is a member of Abingworth LLP ("ALLP"). ALLP provides advisory services to Abingworth Bioventures VI, LP ("ABV VI"). Under an agreement between the Reporting Person and ALLP, the Reporting Person is deemed to hold the Options and any shares of common stock issuable upon exercise of the Options, for the benefit of ABV VI, and must exercise the Options solely upon the direction of ALLP.
- [F3]ABV VI may be deemed the indirect beneficial owner of the Options, and the Reporting Person may be deemed the indirect beneficial owner of the Options through his indirect interest in ABV VI. The Reporting Person disclaims beneficial ownership of the Options except to the extent, if any, of his pecuniary interest therein. This report shall not be deemed an admission that the Reporting Person, ALLP, ABV VI or any other person is the beneficial owner of the securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.
Documents
Issuer
PROTEON THERAPEUTICS INC
CIK 0001359931
Entity typeother
Related Parties
1- filerCIK 0001526068
Filing Metadata
- Form type
- 4
- Filed
- Jun 10, 8:00 PM ET
- Accepted
- Jun 11, 4:33 PM ET
- Size
- 6.7 KB